Lyra Therapeutics, Inc. (LYRA) — Institutional Holders, Q1 2026
1 institutional investment managers reported a LYRA position on SEC Form 13F-HR for the quarter ended March 31, 2026, with a combined reported value of $51.1K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
LYRA in Q1 2026: what funds did
Funds that filed a 13F for both Q4 2025 and Q1 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
None this quarter.
Biggest sellers
- SABBY MANAGEMENTTrimmed · -71,099 sh-$34.9K
- Ikarian CapitalSold out · -21,161 sh-$10.4K
- DRW SecuritiesSold out · -16,812 sh-$8.3K
- GEODE CAPITAL MANAGEMENTSold out · -12,249 sh-$6.0K
- Artia Global PartnersSold out · -8,756 sh-$4.3K
LYRA 13F holders ranked 1–1 of 1
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q4 2025 |
|---|---|---|---|---|---|
| 1 | SABBY MANAGEMENT#1 · 104,059 sh | 104,059 | $51.1K | — | -40.6% |
Funds that sold out of LYRA in Q1 2026 (20)
Held LYRA at the end of Q4 2025 and filed a Q1 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q4 2025 |
|---|---|---|
| Ikarian Capital21,161 sh | 21,161 | $65.2K |
| DRW Securities16,812 sh | 16,812 | $51.8K |
| GEODE CAPITAL MANAGEMENT12,249 sh | 12,249 | $37.7K |
| Artia Global Partners8,756 sh | 8,756 | $27.0K |
| BlackRock2,394 sh | 2,394 | $7.4K |
| Tower Research Capital (TRC)2,191 sh | 2,191 | $6.7K |
| ROYAL BANK OF CANADA1,953 sh | 1,953 | $6.0K |
| UBS Group AG675 sh | 675 | $2.1K |
| EverSource Wealth Advisors338 sh | 338 | $1.0K |
| MORGAN STANLEY334 sh | 334 | $1.0K |
| JONES FINANCIAL COMPANIES LLLP210 sh | 210 | $647.00 |
| BANK OF AMERICA189 sh | 189 | $582.00 |
| SBI Securities , Ltd.80 sh | 80 | $246.00 |
| JPMORGAN CHASE27 sh | 27 | $83.00 |
| OSAIC22 sh | 22 | $67.00 |
| Wilmington Savings Fund Society, FSB20 sh | 20 | $62.00 |
| BNP PARIBAS FINANCIAL MARKETS16 sh | 16 | $49.00 |
| CITIGROUP3 sh | 3 | $9.00 |
| IFP Advisors1 sh | 1 | $3.00 |
| CWM1 sh | 1 | $0.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q1 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q4 2025 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.